“COMPARATIVE IMMUNE MICROENVIRONMENT PROFILING IN HBV-, HCV-, AND DUAL-INFECTED HEPATOCELLULAR CARCINOMA: TOWARD ETIOLOGY-SPECIFIC IMMUNOTHERAPEUTIC TARGETS”. Frontier in Medical and Health Research 3, no. 4 (June 30, 2025): 843–845. Accessed August 16, 2026. https://fmhr.net/index.php/fmhr/article/view/478.